Welcome to the Future of Medicine and Research
SMSbiotech is a San Diego-based biotech company that discovered and named a novel human stem cell and is utilizing it to advance the field of regenerative medicine using an off-the-shelf cell therapy and other approaches.
Small Mobile Stem (SMS) cells derived from adult human blood are unique therapeutic cells equipped with a broad scope of features that overcome deficiencies related to current regenerative cells.
Democratizing the application of adult stem cell technologies for human health.
Regenerative Medicine Enabled by a Novel superior Stem Cell Technology
join usCurrently, many conventional drugs and treatments address patients’ symptoms instead of the root causes of the disease. This approach can result in ongoing health issues like non-healing wounds, degenerative tissues or diseases we merely live with like Chronic Obstructive Pulmonary Disease (COPD), a third leading cause of death worldwide. About 3.5 million death every year according to the WHO.
SMSbiotech’s patented regenerative technology intends to change this status quo. Its approach addresses the lack of ability of many patients to restore cells and tissues damaged by disease, trauma, and aging to positively affect their quality of life and longevity.
A novel, patented approach that produces unique human allogeneic adult Small Mobile Stem (SMS) cells.
The backbone of our treatments
Stem cell enabling technology. Delivering life-changing treatments from human stem cells with unique properties and derived complex proteins.
more infoA novel, patented approach that produces unique human allogeneic adult Small Mobile Stem (SMS) cells.
The challenges
Tissue degeneration is at the root of many chronic and age-related diseases such as COPD, ARDS, and chronic wounds.
more info
Our technological
solutions
Cutting edge technology addressing the two essential components of living tissue; cells and extracellular matrix.
more infoManufactures cells for therapeutic use at an industrial scale. These cells can successfully address chronic lung diseases such as COPD.
Who we are
SMSbiotech was founded based on its revolutionary adult stem cell research. Through hard work and over three decades of experience in research and applications, we have been able to patent a new platform technology based on the unique Small Mobile Stem Cells.
Our technology will change how the life science industry approaches the development of cells and drugs, leading to a paradigm shift and a broad spectrum of medical applications.
SMSbiotech, founded in 2015, is a clinical-stage biotech company established in California. We discovered and named a new stem cell (Small Mobile Stem cell). With this cell, we have created a new, proprietary technology that will change how the life science industry approaches regenerative therapy.
Based on our patented, revolutionary adult stem cell research technologies, new potential treatments can be tested as first in human allogenic off the shelf cell therapy; more cost-effectively than with traditional methods. Based on the unique characteristics of SMS cells (stability at refrigerator temperature, chemical resilience, lack of immunogenicity, selective cell binding, small size, potency...). The SMSbiotech platform technology will penetrate the regenerative medicine and bio-manufacturing markets and lay the groundwork for developing alternative, more efficient, and relevant treatments and medications.
We are only as strong as our team, which involves leading figures in science, medicine, and business. We have undergone several collaborations with select scientific institutions and leading research organizations. We strive to hire and consult with people who share our vision and dedication. Our continued progress since the inception of SMSbiotech is supported through the persistent dedication of its members. We are aiming at disrupting the field of medicine using groundbreaking SMS cell therapy that is broadly effective in many unmet need indications while creating affordable and disease-changing solutions to the public.
Do you want to learn more about us? Contact us!
